Literature DB >> 4101317

Azathioprine in primary sclerosing cholangitif.

S L Javett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4101317     DOI： 10.1016/s0140-6736(71)91261-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis.

Authors:  H Kawai; Y Aoyagi; M Nomoto; H Takizawa; Y Suzuki; A Hama; T Suda; T Takahashi; H Asakura
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

Review 2.  The management of primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

3.  Primary sclerosing cholangitis in India.

Authors:  S K Acharya; S Vashisht; R K Tandon
Journal:  Gastroenterol Jpn       Date:  1989-02

4.  Steroid-responsive (autoimmune?) sclerosing cholangitis.

Authors:  Jasjeet S Sekhon; Raymond T Chung; Mark Epstein; Marshall M Kaplan
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

5.  An unusual cholangitis.

Authors: 
Journal:  Br Med J       Date:  1976-11-06

Review 6.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

7.  Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study.

Authors:  P Angulo; A E Bharucha; R A Jorgensen; C K DeSotel; W J Sandborn; N F Larusso; K D Lindor
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

8.  Primary sclerosing cholangitis: a heterogenous disease.

Authors:  H H Thompson; H A Pitt; R K Tompkins; W P Longmire
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

Review 9.  A review of the medical treatment of primary sclerosing cholangitis in the 21st century.

Authors:  Elizabeth C Goode; Simon M Rushbrook
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

10.  Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; W Irish; J McMichael; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.